Electrocardiographic manifestations of heart metastasis from a primary lung cancer

Vallot, Frédéric; Berghmans, Thierry; Delhaye, François; Dagnelie, Jacques; Sculier, Jean-Paul

doi:10.1007/s005200000212

Cited by 18 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most common ECg abnormalities were inverted T waves in iii and aVF (48.6%), inverted T waves in V 2 -V 4 (41.8%) and ST-segment depression in V 4 -V 6 (26.4%) [21]. Because in our case the ECg showed inversion of T waves in ii, iii, aVF, V 3 -V 6 and ST seg- according to available case reports, any new ECg changes in patients with lung cancer, particularly if they suggest aCS without appropriate symptoms, and are not accompanied by elevated troponin levels, can indicate cardiac metastases [10][11][12][13][14][15][16]. in our case, the stage and location of the tumour suggested cardiac metastases, which may occur in up to 18% of cases of squamous cell lung cancer [22].…”

Section: Case Reportmentioning

confidence: 82%

“…it is important to note that the registration of nonspecific changes in T waves and ST segments on the ECg could be caused by secondary cardiac involvement, which is relatively common in lung cancer compared to other malignancies. However, this is difficult to diagnose before death since cardiac involvement can overlap with the symptoms of disseminated disease [11][12][13].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Electrocardiographic changes in lung cancer. Be careful not to misdiagnose: acute coronary event? meta? inflammation?

Styczkiewicz,

Kostkiewicz,

Górecki

et al. 2024

OncoReview

View full text Add to dashboard Cite

In cancer patients changes in the electrocardiogram (ECG) may indicate various causes. The presented case concerns a patient with advanced left lung cancer who presented deep inversion of T waves during ongoing chemotherapy. We excluded acute coronary syndrome, acute pulmonary embolism, and myocarditis. Subsequently, we suspected metastases to the myocardium; therefore, we performed cardiac magnetic resonance imaging, which however did not confirm that. The cardiac magnetic resonance imaging showed residual post-inflammatory changes in the left lung. We publish this case to show that the inflammatory process of lung segments adjacent to the heart may cause temporal myocardial oedema, resulting in ECG changes that may mimic acute coronary events.

show abstract

Section: Case Reportmentioning

confidence: 82%

Section: Introductionmentioning

confidence: 99%

Electrocardiographic changes in lung cancer. Be careful not to misdiagnose: acute coronary event? meta? inflammation?

Styczkiewicz,

Kostkiewicz,

Górecki

et al. 2024

OncoReview

View full text Add to dashboard Cite

show abstract

Cardiac Complications

Ewer

Suter

2017

Holland‐Frei Cancer Medicine

View full text Add to dashboard Cite

Overview Patients with malignant diseases often have coexisting cardiovascular disorders or may face serious cardiovascular complications in the course of their disease. The disorders may result from underlying conditions such as atherosclerosis, hypertension, or valvular abnormalities, or they may result directly from cancer or its treatment (Table 1). In addition, cardiovascular disorders that are unusual in patients not afflicted with cancer may be more common in the cancer patient and sometimes are unsuspected. Furthermore, cardiovascular diseases common in the general population must not be overlooked in patients with cancer; the presentation of such entities may be unusual, and the diagnosis often is more complex. Increased clinical scrutiny is therefore necessary in this vulnerable population. Multiple clinical problems may also coexist and defy a simple illumination because of the complex interactions between the malignancy, its treatment, and the cardiovascular system; what affects one often alters the presentation and course of the others. This chapter will look at some of the more common cardiovascular complications of cancer and its treatment, and will also address some of the dilemmas encountered in cancer patients with concomitant cardiac conditions.

show abstract

Cardiac Complications

Ewer¹,

Ewer²,

Suter³

2022

Holland‐Frei Cancer Medicine

View full text Add to dashboard Cite

Overview Patients with malignant diseases often have coexisting cardiovascular disorders or may face serious cardiovascular complications in the course of their disease. 1 The disorders may result from underlying conditions such as atherosclerosis, hypertension, or valvular abnormalities, or they may result directly from cancer or its treatment (Table 1). In addition, cardiovascular disorders that are unusual in patients not afflicted with cancer may be more common in the cancer patient, and sometimes are unsuspected. Furthermore, cardiovascular diseases common in the general population must not be overlooked in patients with cancer; the presentation of such entities may be unusual, and the diagnosis often is more complex. Increased clinical scrutiny is therefore necessary in this vulnerable population. Multiple clinical problems may also coexist and defy a simple illumination because of the complex interactions between the malignancy, consequences of its treatment, and the status of the cardiovascular system; what affects one of these variables often alters the presentation and course of the others. This article will look at some of the more common cardiovascular complications of cancer and its treatment and will also address some of the dilemmas encountered in cancer patients with concomitant cardiac conditions.

show abstract

Electrocardiographic manifestations of heart metastasis from a primary lung cancer

Cited by 18 publications

References 8 publications

Electrocardiographic changes in lung cancer. Be careful not to misdiagnose: acute coronary event? meta? inflammation?

Electrocardiographic changes in lung cancer. Be careful not to misdiagnose: acute coronary event? meta? inflammation?

Cardiac Complications

Cardiac Complications

Contact Info

Product

Resources

About